Atlas Trials

Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS

Clinical trial NCT03187288 · COMPLETED

Trial details

NCT number
NCT03187288
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaMyelodysplastic SyndromesRelapsed CancerRefractory Cancer
Start date
2018-05-25
Primary completion
2021-06-30
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.